Xvivo Perfusion AB (publ) (LON: 0RKL)

Market Cap	968.17M
Revenue (ttm)	55.22M
Net Income (ttm)	15.03M
Shares Out	n/a
EPS (ttm)	0.48
PE Ratio	64.43
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,687
Average Volume	7,481
Open	432.50
Previous Close	449.50
Day's Range	416.50 - 434.00
52-Week Range	205.50 - 434.00
Beta	2.13
RSI	29.73
Earnings Date	Jan 27, 2025

About Xvivo Perfusion AB

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden, the United States, the Netherlands, Italy, North and South America, Europe, the Middle East, Africa, the Asia Pacific, and Oceania. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a c...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1998
• Employees: 160
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RKL

Financial Performance

In 2023, Xvivo Perfusion AB's revenue was 597.54 million, an increase of 43.88% compared to the previous year's 415.29 million. Earnings were 91.82 million, an increase of 398.29%.

Financial numbers in SEK